Journey Medical Corporation Quarterly report pursuant to Section 13 or 15(d)

INTEREST EXPENSE

9 Months Ended

Sep. 30, 2022

NOTE 14. INTEREST EXPENSE

Interest expense consisted of the following:


	Three-month periods ended				Nine-month periods ended
	September 30,				September 30,
	2022		2021		2022		2021
Interest payments on EWB term loan	$	333	$	—	$	710	$	—
Imputed Interest on acquired intangible assets		136		180		435		626
Amortization/Accretion		90		—		257		—
Fees on convertible preferred shares		—		378		—		648
Conversion premium ¹		—		365		—		628
Interest payable on convertible preferred shares		—		450		—		1,034
Total Interest Expense and Financing Fee	$	559	$	1,373	$	1,402	$	2,936

¹The conversion premium relates to the 15% discount at which the Class A Preferred Stock converted.